triphenyltetrazolium has been researched along with glycine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisher, M; Meiler, MR; Takano, K; Tatlisumak, T | 1 |
| Baĭsa, AE; Burov, SV; Chefu, SG; Leko, MV; Veselkina, OS; Vlasov, TD | 1 |
2 other study(ies) available for triphenyltetrazolium and glycine
| Article | Year |
|---|---|
A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
Topics: Analysis of Variance; Animals; Cerebral Arterial Diseases; Cerebral Cortex; Cerebral Infarction; Coloring Agents; Cortical Spreading Depression; Electroencephalography; Glycine; Infusions, Intravenous; Injections, Intravenous; Ischemic Attack, Transient; Linear Models; Male; N-Methylaspartate; Neuroprotective Agents; Placebos; Pyridazines; Quinolines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Single-Blind Method; Tetrazolium Salts | 1998 |
[Amides of creatine: perspectives of neuroprotection].
Topics: Amides; Animals; Brain Ischemia; Creatine; Female; gamma-Aminobutyric Acid; Glycine; Hemodynamics; Image Processing, Computer-Assisted; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Injections, Intravenous; Ischemic Attack, Transient; Male; Microscopy; Microtomy; Models, Animal; Neuroprotective Agents; Phenylalanine; Rats; Rats, Wistar; Tetrazolium Salts; Tyrosine | 2011 |